Organisation for Anticonvulsant Syndromes Ireland Annual Report.

2019 proved a landmark year for OACS Ireland. Our organisation has been in existence for just over a year but 2019 was a year of considerable progress. We were approved as a charity by the Charities Regulator which means we can now apply for and receive funding for our work. We are grateful to the Irish Hospitals Saturday Fund for their financial support to date. During 2019 we made significant progress working with the HPRA to improve the labeling on the anti-epileptic drug Epilim (sodium valproate). This will alert pharmacist, doctors and users of Epilim to its potential implications if taken prior to and during pregnancy.

OACS Ireland